글로벌 혈당 모니터링 시스템 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 혈당 모니터링 시스템 시장

혈당 모니터링 시스템 시장은 2021년부터 2028년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2021년부터 2028년까지의 예측 기간 동안 8.24%의 CAGR로 성장하고 있으며 2028년까지 261억 3천만 달러에 도달할 것으로 예상된다고 분석했습니다. 전 세계 인구 중 당뇨병 사례 유병률이 증가함에 따라 혈당 모니터링 시스템 시장이 확대되고 있습니다.

혈당 모니터링 시스템은 당뇨병 환자의 모니터링 및 치료에 사용되는 진단 시스템을 말합니다. 당뇨병은 만성 질환으로, 환자의 혈당 수치를 정기적으로 측정하고 모니터링하지 않으면 신장 손상, 뇌졸중, 심지어 심장마비와 같은 심각한 결과를 초래할 수 있습니다. 일반적으로 모니터링 시스템은 혈액 샘플을 채취하지만 기술의 발전으로 센서를 사용하여 지속적인 모니터링을 실시하고 있습니다.

The rise in the number of diabetic patients globally and the increasing demand for the monitoring systems because of the growth in population are the major factors driving the blood glucose monitoring system market. The rise in demand for blood glucose monitoring system owning to its features such as economic efficiency and accurate diagnosis and treatment accelerate the blood glucose monitoring system market growth. The availability of different blood glucose monitors varying in ease of use, size, length of testing time and price and the effective approach of these medical devices in preventing other health conditions including retinopathy, cardiovascular diseases and neuropathy also influence the blood glucose monitoring system market. Additionally, the change in lifestyles of people such as consumption of alcohol and unhealthy food, smoking, increasing rate of obesity cases, growing geriatric population and rise in awareness regarding diabetes preventive care positively affect the blood glucose monitoring system market. Furthermore, technological advancement leading to early detection of hypo and hyperglycemic diabetes, support from the government and launch of new products extend profitable opportunities to the blood glucose monitoring system market players in the forecast period of 2021 to 2028.    

On the other hand, the volatile economic distribution in the developing nations and the availability of cheap alternative devices are expected to obstruct the blood glucose monitoring system market growth. The implementation of stringent regulatory norms and decreasing investment in laboratories are projected to challenge the blood glucose monitoring system market in the forecast period of 2021-2028.

This blood glucose monitoring system market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on blood glucose monitoring system market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Blood Glucose Monitoring System Market Scope and Market Size

The blood glucose monitoring system market is segmented on the basis of product, testing site, patient care setting and application. The growth amongst these segments will help you analyze meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of product, the blood glucose monitoring system is segmented into self-monitoring systems and continuous blood glucose monitoring systems. Self-monitoring devices are further segmented into blood glucose meter, testing strips and lancets. Continuous blood glucose monitoring devices are further segmented into sensors, transmitter and receiver and lancets.
• On the basis of testing site, the blood glucose monitoring system is segmented into fingertip and alternate site.
• On the basis of patient care setting, the blood glucose monitoring system is segmented into self/home care, hospital and clinics.
• On the basis of application, the blood glucose monitoring system is segmented into type 2 diabetes, type 1 diabetes and gestational diabetes.

Global Blood Glucose Monitoring System Market Country Level Analysis

The blood glucose monitoring system is analyzed and market size insights and trends are provided by country, product, testing site, patient care setting and application as referenced above.      

The countries covered in the blood glucose monitoring system report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the blood glucose monitoring system because of the rise in the obese population, well-developed healthcare infrastructure, increasing technological investment, new medical products and high cost of treatments in the region. Asia-Pacific is estimated to grow in the forecast period of 2021-2028 due to the large diabetic population, rise in awareness about diabetes preventive care, favorable reimbursement policies and enhancement in healthcare facilities in the region.

The country section of the blood glucose monitoring system report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

의료 인프라 성장 설치 기반 및 신기술 침투

혈당 모니터링 시스템은 또한 모든 국가에 대한 자세한 시장 분석을 제공합니다. 자본 장비에 대한 의료 지출 증가, 혈당 모니터링 시스템을 위한 다양한 종류의 제품 설치 기반, 수명선 곡선을 사용한 기술의 영향, 의료 규제 시나리오의 변화 및 혈당 모니터링 시스템에 미치는 영향. 이 데이터는 2010-2019년의 과거 기간에 대해 제공됩니다.

경쟁 환경 및 혈당 모니터링 시스템 시장 점유율 분석

혈당 모니터링 시스템 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, 연구 개발 투자, 새로운 시장 이니셔티브, 글로벌 입지, 생산 현장 및 시설, 생산 용량, 회사의 강점과 약점, 제품 출시, 제품 폭과 범위, 애플리케이션 우세입니다. 위에 제공된 데이터 포인트는 혈당 모니터링 시스템과 관련된 회사의 초점에만 관련이 있습니다.

혈당 모니터링 시스템 보고서에서 다루는 주요 기업으로는 Medtronic, Abbott, F. Hoffmann-La Roche Ltd, Johnson & Johnson Services Inc., PHC Holdings Corporation, Dexcom Inc., Ypsomed, B. Braun Melsungen AG, NIPRO, Sanofi, ARKRAY Inc., Prodigy Diabetes Care LLC, ACON Laboratories Inc., Nova Biomedical, Bayer AG, BD, Roper Technologies Inc., TERUMO CORPORATION, Novo Nordisk A/S, Eli Lilly and Company, LifeScan IP Holdings, LLC 등이 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA), 남미에 대해 개별적으로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 개별적으로 제공합니다.

SKU-27369